ONCOGENEX PHARMACEUTICALS IN - COM (OGXI)

CUSIP: 68230A106

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
6,967,377
Share change
0
Total reported value
$58,108,108
Put/Call ratio
4025%
Price per share
$8.34
Number of holders
67

Quarterly Holders Quick Answers

What is CUSIP 68230A106?
CUSIP 68230A106 identifies OGXI - ONCOGENEX PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) as of Q4 2013

As of 31 Dec 2013, ONCOGENEX PHARMACEUTICALS IN - COM (OGXI) was held by 67 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,967,377 shares. The largest 10 holders included TANG CAPITAL MANAGEMENT LLC, BlackRock Institutional Trust Company, N.A., ABINGWORTH LLP, Visium Asset Management, LP, BlackRock Fund Advisors, SABBY MANAGEMENT, LLC, Allianz Asset Management AG, FMR LLC, BlackRock Advisors LLC, and NORTHERN TRUST CORP. This page lists 67 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.